Pahuja S L, Zielinski J E, Giordano G, McMurray W J, Hochberg R B
Department of Obstetrics and Gynecology, Yale University School of Medicine, New Haven, Connecticut 06510.
J Biol Chem. 1991 Apr 25;266(12):7410-6.
Biological esterification with fatty acids is a feature that is now known to be common to most steroids. The esterification of estradiol in the D-ring at the 17 beta-hydroxyl leads to a family of extremely active estrogens. Similarly, esterification of the weaker estrogen, estriol (E3), has an even greater impact on its hormonal potency. We have recently shown that synthetic long chain esters of E3 at either 16 alpha- or 17 beta- are highly potent estrogens. The estrogenic activity of the synthetic E3 esters led us to determine whether E3 is biologically esterified, and if so, to characterize the resulting esters. Incubation of E3 with rat lung, a tissue which is highly active in esterifying estradiol, produces a nonpolar metabolite which upon saponification is converted back into E3. There was no evidence for the formation of a diester. Purification by high performance liquid chromatography separates the non-polar metabolite into two peaks, one the C-16 alpha- (approximately 60%) and the other the C-17 beta-ester (approximately 40%). The two fractions were further purified and characterized; each is a mixture of fatty acid esters of E3. The composition of the C-16 alpha- and the C-17 beta-fatty acid esters of E3 is identical. The predominant fatty acids are arachidonate, 34%, palmitate, 26%, followed by oleate 14%, linoleate 13%, stearate 8%, and palmitoleate 5%. The similarity of the esters at C-16 and C-17 may indicate that the fatty acid precursor for the acyltransferase is the same for both hydroxyl groups. It may also suggest that the same enzyme esterifies both positions in the D-ring. Since synthetic estriol fatty acid esters are extremely potent and long-lived estrogens, the enzymatic esterification of estriol produces powerful estrogens with considerable physiological potential.
与脂肪酸的生物酯化是目前已知大多数类固醇共有的一个特征。雌二醇在D环17β-羟基处的酯化产生了一系列活性极高的雌激素。同样,较弱的雌激素雌三醇(E3)的酯化对其激素效力有更大影响。我们最近发现,16α-或17β-位的E3合成长链酯是高效雌激素。合成E3酯的雌激素活性促使我们确定E3是否会发生生物酯化,如果是,则对生成的酯进行表征。将E3与大鼠肺(一种在雌二醇酯化方面非常活跃的组织)一起孵育,会产生一种非极性代谢物,皂化后可转化回E3。没有证据表明会形成二酯。通过高效液相色谱法纯化可将非极性代谢物分离为两个峰,一个是C-16α-酯(约60%),另一个是C-17β-酯(约40%)。这两个馏分进一步纯化并表征;每个都是E3脂肪酸酯的混合物。E3的C-16α-和C-17β-脂肪酸酯的组成相同。主要脂肪酸是花生四烯酸,占34%,棕榈酸,占26%,其次是油酸14%、亚油酸13%、硬脂酸8%和棕榈油酸5%。C-16和C-17位酯的相似性可能表明,酰基转移酶的脂肪酸前体对于两个羟基是相同的。这也可能表明同一种酶使D环中的两个位置发生酯化。由于合成雌三醇脂肪酸酯是极其强效且长效的雌激素,雌三醇的酶促酯化产生了具有相当生理潜力的强效雌激素。